World leader in probiotic products
BioGaia is a Swedish world-leading probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets and sells probiotic products with documented health benefits. The company operates throughout the value chain, partly within the company and partly through global networks of leading, independent researchers and specialists, production experts and local distribution partners. The distribution partners are nutrition and pharmaceutical companies, selling BioGaia’s products in more than 100 countries.
BioGaia’s products contain strains of the lactic acid bacterium L. reuteri (Limosilactobacillus reuteri, formerly known as Lactobacillus reuteri). L. reuteri is one of few bacteria that has co-evolved with humans and because of this it naturally colonises and has a strong adaptation and interacts with us. Results from clinical studies with BioGaia’s probiotic strains have been published in more than 200 articles in scientific journals, proving them effective and safe in children and adults.
BioGaia wants to contribute to better health in the world by developing and offering clinically-proven and user-friendly probiotic products.
Contact us Our products
Investors
BioGaia’s class B share are listed on the Mid Cap segment of the Nasdaq OMX Nordic Stockholm exchange. Read more
Our business model
Thanks to a successful business model, BioGaia has been able to grow globally with a lean, efficient and agile organization. BioGaia’s business model is based on three external networks – research, production and distribution. Read more
Distribution network
BioGaia's products are sold through around 80 local distribution partners in 100 countries around the world.
Read more
BioGaia's history
BioGaia´s history goes back to the 1980´s, at the time when HIV was discovered. The two scientists Sven Lindgren and Walt Dobrogosz were investigating different probiotics in order to see what effects they had in this area. Read more
Read more
Probiotic supplements
BioGaia's products are sold through around 80 local distribution partners in 100 countries around the world.
Read more
Our research
To date, 224 clinical studies using BioGaia’s human strains of L. reuteri have been performed on 18,000 individuals of all ages. (May 2020)
Read more
Sustainability
We have a strategy with a long-term approach and clear goals, structure and priorities for our sustainability initiatives.
Read more
